Skip to main content
OpenTrials

Clinical trial condition

Pneumococcal Infections

Explore clinical trials studying Pneumococcal Infections. Study availability and eligibility vary by location and protocol.

118 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Pneumococcal Infections trial results

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)

NCT04384107

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Morinaga Maternity Clinic ( Site 3345) Kasugai, Aichi-ken, Japan
  • Social Medical Corporation Koujunkai Daido Clinic ( Site 3326) Nagoya, Aichi-ken, Japan
  • Kyoritsu Narashinodai Hospital ( Site 3332) Funabashi, Chiba, Japan
  • Sotobo Children's Clinic ( Site 3323) Isumi, Chiba, Japan
View all 45 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK)

NCT03692871

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Premier Health Research Center, LLC ( Site 0005) Downey, California, United States
  • Beach Pediatrics ( Site 0040) Huntington Beach, California, United States
  • Khruz Biotechnology Research Institute ( Site 0006) San Diego, California, United States
  • Kaiser Permanente - San Jose ( Site 0036) San Jose, California, United States
View all 76 locations
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

NCT03893448

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Alabama Clinical Therapeutics ( Site 0159) Birmingham, Alabama, United States
  • Southeastern Pediatric Associates, P.A. ( Site 0107) Dothan, Alabama, United States
  • South Alabama Pediatrics ( Site 0263) Opp, Alabama, United States
  • Northwest Arkansas Pediatric Clinic ( Site 0172) Fayetteville, Arkansas, United States
View all 81 locations
View Trial Details
Completed

Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED)

NCT03921424

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Perinatal HIV Research Unit ( Site 0042) Johannesburg, Gauteng, South Africa
  • Wits Reproductive Health and HIV Institute (WRHI) ( Site 0043) Johannesburg, Gauteng, South Africa
  • Family Clinic Research With UBUNTU ( Site 0045) Cape Town, Western Cape, South Africa
  • Be Part Yoluntu Centre ( Site 0041) Paarl, Western Cape, South Africa
View all 13 locations
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)

NCT04016714

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Hvidovre Hospital ( Site 0003) Hvidovre, Capital Region, Denmark
  • Aarhus Universitetshosp. Skejby ( Site 0002) Aarhus, Central Jutland, Denmark
  • Regionshospitalet Herning Hospitalsenheden Vest ( Site 0006) Herning, Central Jutland, Denmark
  • Aalborg Universitetshospital ( Site 0005) Aalborg, North Denmark, Denmark
View all 24 locations
View Trial Details
Completed

A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)

NCT03620162

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Alabama Clinical Therapeutics ( Site 0015) Birmingham, Alabama, United States
  • Southeastern Pediatric Associates, P.A. ( Site 0002) Dothan, Alabama, United States
  • Children's Clinic of Jonesboro, PA ( Site 0022) Jonesboro, Arkansas, United States
  • Davita Medical Group ( Site 0012) Colorado Springs, Colorado, United States
View all 34 locations
View Trial Details
Completed

Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024)

NCT03885934

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007) Espoo, Finland
  • Tampereen yliopisto Etelä-Helsingin rokotetutkimusklinikka ( Site 0005) Helsinki, Finland
  • Tampereen yliopisto Ita-Helsingin rokotetutkimusklinikka ( Site 0006) Helsinki, Finland
  • Tampereen yliopisto Järvenpään rokotetutkimusklinikka ( Site 0003) Jarvenpaa, Finland
View all 26 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)

NCT03480802

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Bliss Healthcare Services ( Site 0010) Orlando, Florida, United States
  • Triple O Research Institute, P.A. ( Site 0011) West Palm Beach, Florida, United States
  • Saint Hope Foundation, Inc. ( Site 0009) Houston, Texas, United States
  • The Crofoot Research Center, Inc. ( Site 0002) Houston, Texas, United States
View all 13 locations
View Trial Details

Related conditions